Ulotaront, a novel TAAR1 agonist with 5-HT1A agonist activity, lacks abuse liability and attenuates cocaine cue-induced relapse in rats

2 Likes

Can someone in plain English describe the ammount of effect Ulotaront has on negative symptoms. There are a few people on Reddit who are talking about “nothing gets rid of negative symptoms” and even if you switch to a non dopamine thing it’s not going to get rid of negative symptoms. Can someone describe the latest results from the PANNS and BNSS